Key Data in Endometrial Cancer From ASCO 2023 Key Data in Endometrial Cancer From ASCO 2023

Top abstracts in endometrial cancer from ASCO 2023 include patient-reported outcomes in the RUBY trial, genetic testing referral rates, and the impact of MMR deficiency on immunotherapy responses.Medscape

Source: Medscape Today Headlines - June 27, 2023 Category: Consumer Health News Tags: None ReCAP Source Type: news